3/27/2023Hepalink's OncoVent Enter License Deal with Orient EuroPharma for Oreg...

3/24/2023InvoX Pharma's F-star Announces 2nd Licence Deal with Takeda

3/24/2023Brii Bio Drops Once-promising COVID Cocktail for Variants

3/24/2023AstraZeneca's Blood Cancer Drug Calquence Gets Conditional Approval in...

3/24/2023NMPA Publishes the 2022 Annual Report for Adverse Drug Reaction Monito...

3/24/2023NMPA Issues the Procedures for Adjustment of Published Reference Formu...

3/24/2023CDE Issues the "Common Pharmacy Issues and Related Technical Requireme...

3/24/2023CDE Issues the Technical Guidelines for Clinical Research and Developm...

3/24/2023Pfizer Signs MOU with HCRC Aimed at Improving Rural Health in China

3/24/2023New Report: Incidence of Moderate and Severe Ovarian Hyperstimulation ...

3/24/2023Drug R&D and Product Registration News Digest March 2023 (4)

3/24/2023U.S.-China Collaboration Could Cut Development Time, Cost For New Canc...

3/23/2023Roche, CR Pharma Tie Up to Improve Access of Flu Drug Xofluza in Chna

3/23/2023Chinese Government Issues the Opinions for Further Improving Healthcar...

3/23/2023CDE Solicits Comments on the Dossier Requirements for Marketing Regist...

3/22/2023Biohaven Licenses ex-China Rights of Highlightll Pharma's TYK2/JAK1 Du...

3/22/2023NMPA Issues Announcement for Applicability of ICH Guidelines S1B(R1)/Q...

3/22/2023CDE Solicits Comments on the Technical Guidelines for Virus Removal/In...

3/22/2023TaiGen Enters Exclusive License Agreement with Joincare for Pan-influe...

3/21/2023Chinese NCE Drug Approval in 2022: Import vs. Domestic

3/21/2023Review of Chinese Drug Registration Application and Evaluation in 2022

3/21/2023Bayer, Orion's Nubeqa Gets Approval in China for Expanded Use in Prost...

3/21/2023CDE Issues the Technical Guidelines for Clinical Research and Developm...

3/21/2023CDE Issues the Technical Guidelines for Writing of Pharmacy Informatio...

3/21/2023CDE Issues the Technical Guidelines for Continuous Manufacturing of Ch...

3/21/2023Therapeutic Antibody Licensing Deals in China: A 2022 End-Of-Year Summ...

3/20/2023New Report: China Cell Therapy Market Opportunity & Clinical Trials In...

3/20/2023TOT Biopharm Terminates Development of Its HER2 ADC TAA013 in China Du...

3/17/2023BeiGene Drops Licensing Option for Leap Thera's I/O Candidate DKN-01

3/17/2023J&J and Legend Shelve Carvykti's UK Launch amid Manufacturing Shortfa...

Page:52/719 Total number of articles:21546: [First][<<] [50] [51] [52] [53] [54] [>>] [End]